Outcomes in Lung Transplantation Following Allogeneic Stem-Cell Transplantation: A Pan-European Experience
Maura Iversen
Part of the Critical Care Commons
Works by M. Iversen in Critical Care
2016
2015
Long Term Outcomes in Thoracic Transplant Recipients After Conversion to Everolimus With Reduced Calcineurin Inhibitor Within a Multicenter, Open-Label, Randomized Trial
Maura Iversen
2014
Restrictive Allograft Syndrome (RAS) in Lung Transplant Recipients Carries Uncertain Additional Prognostic Significance as Compared To BOS
Maura Iversen
Age-Related Decline in Lung Function in Patients Without CLAD After Double Lung Transplantation
Maura Iversen
2012
526 Chronic Allograft Dysfunction after Lung Transplantation. A Comparison of RAS vs. BOS
Maura Iversen
726 Endoscopic Treatment of Native Lung Hyperinflation with One-Way Valves in Single Lung Transplant Patients: A Multinational Experience
Maura Iversen
823 Impact of Pulmonary Venous Hypertension on Prognosis and Outcome after Lung Transplantation for End-Stage Chronic Obstructive Pulmonary Disease
Maura Iversen
2011
224 Nontuberculous mycobacterial infections among cystic fibrosis patients undergoing lung transplantation
Maura Iversen
226 Lung transplant patients with cystic fibrosis attain lower blood concentrations of cyclosporine compared to other lung transplant patients
Maura Iversen
53 Everolimus Introduction and Calcineurin Reduction in Thoracic Transplant Recipients with Advanced Chronic Renal Failure
Maura Iversen
2010
132: Everolimus Introduction with CNI Minimization Significantly Improves Renal Function in Thoracic Transplant Recipients: A Scandinavian Multicenter, Randomized Study
Maura Iversen
2009
317: Does Ciclosporine C2 Levels Determine Outcome in De Novo Heart and Lung Transplant Patients: Results from the NOCTURNE Nordic Multi Centre Study
Maura Iversen
2008
212: An Analysis of 2697 Transbronchial Biopsies: Is Lymphocytic Bronchiolitis a Marker of Acute Rejection?
Maura Iversen
530: Microarray Based Measurement of Autoantibodies Identifies Early Development of BOS in Lung Transplant Patients
Maura Iversen
86: Analysis of Risk Factors for the Development of Bronchiolitis Obliterans Syndrome (BOS) after Lung Transplantation
Maura Iversen
111: Bronchiolitis Obliterans Organizing Pneumonia (BOOP) after Lung Transplantation: A Potentially Reversible Prelude to Bronchiolitis Obliterans?
Maura Iversen
2007
353: Pulmonary arterial hypertension in end-stage pulmonary sarcoidosis: Assessment of the therapeutic effect of sildenafil
Maura Iversen
2006
381: Histological appearances in patients with radiologically defined primary graft dysfunction (PGD)
Maura Iversen